MediciNova, Inc. (MNOV) DCF Valuation

MediciNova, Inc. (MNOV) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

MediciNova, Inc. (MNOV) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your MediciNova, Inc. (MNOV) valuation analysis using our cutting-edge DCF Calculator! This Excel template comes preloaded with real MNOV data, enabling you to adjust forecasts and assumptions for an accurate calculation of MediciNova's intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 4.0 .0 1.0 .8 .6 .4 .3 .2
Revenue Growth, % 0 0 0 -100 0 -25 -25 -25 -25 -25
EBITDA -14.0 -14.2 -10.2 -13.9 -9.9 .2 .1 .1 .1 .0
EBITDA, % 100 100 -252.38 100 -988 20 20 20 20 20
Depreciation .0 .0 .0 .2 .0 .5 .3 .3 .2 .1
Depreciation, % 100 100 0.64765 100 2.03 60.54 60.54 60.54 60.54 60.54
EBIT -14.0 -14.2 -10.2 -14.1 -9.9 .2 .1 .1 .1 .0
EBIT, % 100 100 -253.02 100 -990.03 20 20 20 20 20
Total Cash 63.8 60.0 71.4 58.5 51.0 .8 .6 .4 .3 .2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 0 100 0
Inventories .0 .0 .0 .0 .0 .5 .3 .3 .2 .1
Inventories, % 100 100 0 100 0 60 60 60 60 60
Accounts Payable .5 .6 .4 .4 1.0 .6 .5 .3 .3 .2
Accounts Payable, % 100 100 9.97 100 100.39 81.99 81.99 81.99 81.99 81.99
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -0.71163 100 -2.13 -0.56831 -0.56831 -0.56831 -0.56831 -0.56831
Tax Rate, % -0.03556061 -0.03556061 -0.03556061 -0.03556061 -0.03556061 -0.03556061 -0.03556061 -0.03556061 -0.03556061 -0.03556061
EBITAT -14.0 -14.2 -10.2 -14.1 -9.9 .1 .1 .1 .1 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -13.6 -14.0 -10.4 -13.8 -9.3 -.7 .5 .4 .3 .2
WACC, % 8.07 8.07 8.07 8.07 8.07 8.07 8.07 8.07 8.07 8.07
PV UFCF
SUM PV UFCF .5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 4
Present Terminal Value 3
Enterprise Value 3
Net Debt -51
Equity Value 54
Diluted Shares Outstanding, MM 49
Equity Value Per Share 1.10

What You Will Get

  • Real MNOV Financial Data: Pre-filled with MediciNova’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See MediciNova’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Data: MediciNova's historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Observe MediciNova's intrinsic value recalculating instantly.
  • Intuitive Visual Outputs: Dashboard charts illustrate valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  • Step 1: Download the prebuilt Excel template with MediciNova, Inc. (MNOV) data included.
  • Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including MediciNova, Inc. (MNOV)'s intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose This Calculator for MediciNova, Inc. (MNOV)?

  • Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for MediciNova, Inc. (MNOV).
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for MediciNova, Inc. (MNOV).
  • Detailed Insights: Automatically computes MediciNova, Inc. (MNOV)’s intrinsic value and Net Present Value.
  • Preloaded Data: Features historical and forecasted data specific to MediciNova, Inc. (MNOV) for precise analysis.
  • Professional Quality: Perfect for financial analysts, investors, and consultants focusing on MediciNova, Inc. (MNOV).

Who Should Use This Product?

  • Healthcare Researchers: Explore innovative treatment options and analyze clinical trial data relevant to MediciNova, Inc. (MNOV).
  • Pharmaceutical Academics: Integrate advanced models into your studies or research projects involving drug development.
  • Investors: Evaluate your investment strategies and assess the potential of MediciNova, Inc. (MNOV) in the biotech sector.
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms like MediciNova, Inc. (MNOV).
  • Entrepreneurs: Understand the valuation processes of publicly traded biotech companies and apply these insights to your own ventures.

What the Template Contains

  • Pre-Filled Data: Includes MediciNova’s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze MediciNova’s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.